Moderna on Thursday lowered its 2022 sales guidance for its Covid-19 vaccine after missing Wall Street expectations for the third quarter. Moderna cut its guidance to between $18 billion and $19 billion in revenue from its Covid vaccine this year, down from its previous expectation […]
Month: November 2022
Magic mushroom compound psilocybin can help treat depression, study finds
LONDON — The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest trial of its type ever conducted. Psilocybin was given to 233 patients who had already tried at least two antidepressants in the past with little […]
2 takeaways from our daily meeting: Stocks await Fed decision, Club earnings recap
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Fed decision ahead Quick takes on Club earnings 1. Fed decision ahead Stocks edged down Wednesday ahead of the Federal […]
We’re impressed with health insurer Humana’s solid quarter and rosy outlook for next year
Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased […]
Eli Lilly’s guidance cut is about the strong dollar, not weakening fundamentals, CEO says
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in […]
Eli Lilly’s guidance cut is about the strong dollar, not weakening fundamentals, CEO says
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in […]
J&J’s nearly $17 billion offer to buy a heart pump maker goes right to why we own it
Johnson Johnson ‘s (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business ahead of J J’s plans to separate its consumer division into a separate company. The Abiomed acquisition is set to close at the […]
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics
Pfizer CEO Albert Bourla laid out his plan Tuesday to keep the pharmaceutical giant growing through 2030, as the Covid-19 pandemic fades and the company faces generic competition for some of its blockbuster drugs. Bourla said Pfizer is staring down an expected loss of between […]
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company’s data shows
Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to the mothers late in their pregnancy, according to clinical trial data published Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, […]
Pfizer raises 2022 earnings guidance, beats third-quarter expectations
WATCH LIVE In this article PFE Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that beat Wall Street expectations. It now expects earnings per share of $6.40 to $6.50 for the year, up from its previous forecast of $6.30 […]